Joseph Loscalzo, Director at IONIS PHARMACEUTICALS INC (IONS), sold 27,016 shares at $37.86 ($1.0M) on 2024-11-12, disclosed to the SEC on 2024-11-14.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.86 | 13,508 | $511K | 50.0% |
| 2 | $37.86 | 13,508 | $511K | 50.0% |
| Total | $37.86 avg | 27,016 | $1.0M | 100% |
| Filing → |
| IONS | SELL | 2025-11-03 | $1.2M | — | Filing → |
| IONS | SELL | 2025-09-04 | $962K | — | Filing → |